Open Access

Poster Session 6 - Pharmacogenetics - New sights on the horizon

Event: ESC Congress 2018
Topic: European Society of Cardiology, Other
Session type: Poster Session
Date: 28 August 2018


6 presentations in this session

HDL-cholesterol dysfunction and inflammation in patients with genotypes associated with different responses to dalcetrapib

Speaker: Doctor A. Franci (Sao Paulo, BR)

Association of CYP2C19*2 and PEAR1 gene variant with platelet reactivity and clinical outcomes in patients undergoing stenting and treated with aspirin and clopidogrel

Speaker: Doctor K. Xu (Shanghai, CN)

CYP2C19 genotyping as complementary tool for guidance of early de-escalation of antiplatelet treatment in acute coronary syndrome patients

Speaker: Doctor L. Gross (Munich, DE)

Prasugrel or clopidogrel in non-st-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention

Speaker: Doctor S. Kim (Busan, KR)

Comparison of three different platelet function tests in patients on P2Y12 inhibitors in correlation to genetic background.

Speaker: Mrs R. Olie (Maastricht, NL)

Genetic influence on warfarin dose determination

Speaker: Doctor J. Li (Busan, KR)

6 speakers from this session

Doctor Andre Franci

Instituto do Coracao FMUSP, Sao Paulo (Brazil)
0 follower

Doctor Ke Xu

Shanghai Chest Hospital, Shanghai (China)
0 follower

Doctor Lisa Gross

Ludwig-Maximilians University, Department of Cardiology, Munich (Germany)
0 follower

Doctor Soojin Kim

, Busan (Korea (Republic of))
0 follower

Mrs Renske Olie

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))
0 follower

Doctor Jia Xin Li

, Busan (Korea (Republic of))
0 follower

This platform is supported by

logo Novo Nordisk